Brainstorm Cell Therapeutics | BCLI - Ordinary Share Capital


Brainstorm Cell Therapeutics reported $11.04M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Biogen USD 146.7M 200K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 0 Mar/2026
Cipla INR 807.78M 17K Mar/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1000 Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 124.43M 2.17M Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 114.04M 4.48M Jun/2026
Mesoblast USD 1.29B 8.58M Dec/2025